Literature DB >> 25656740

Shigella flexneri serotype 1 infections in men who have sex with men in Vancouver, Canada.

A Wilmer1, M G Romney, R Gustafson, J Sandhu, T Chu, C Ng, L Hoang, S Champagne, M W Hull.   

Abstract

OBJECTIVES: Outbreaks of shigellosis have been documented in men who have sex with men (MSM), associated with interpersonal transmission and underlying HIV infection. We observed a rise in Shigella flexneri isolates identified in a downtown tertiary-care hospital laboratory located within the city centre community health area (CHA-1) of Vancouver, Canada. The objectives of this study were to evaluate clinical outcomes of shigellosis cases among MSM admitted to hospital and to evaluate trends in Shigella cases within Vancouver, Canada.
METHODS: Adult rates of shigellosis were analysed by gender and health region, from 2005 to 2011, followed by retrospective chart review of all hospital laboratory-identified S. flexneri cases from 2008 to 2012. Serotyping and pulsed-field gel electrophoresis (PFGE) were performed on these isolates.
RESULTS: Although shigellosis rates in men within CHA-1 did not change from 2005 to 2011 (range 33.4-68.5 per 100 000; P = 0.74), they were significantly higher than in other regions within the city of Vancouver (P ≤ 0.001) and the province of British Columbia (P ≤ 0.001). Shigella flexneri rates in men within CHA-1 increased significantly (range 2.3-51.4 per 100 000; P < 0.001), starting in 2008, and were higher than in other regions within Vancouver (P ≤ 0.01). Seventy-nine isolates of S. flexneri from 72 patients were identified by a single hospital laboratory. All patients were male and predominantly MSM (91.7%) and HIV-infected (86.1%), with most (92.6%) demonstrating CD4 counts ≥ 200 cells/μL. In total, 38.0% required hospitalization. Most (87.3%) had S. flexneri serotype 1 infection, with 72.9% of these representing a single PFGE pattern.
CONCLUSIONS: We identified high levels of transmission of a primarily clonal strain of S. flexneri serotype 1 in our local MSM population, resulting in a substantial burden of illness and health care resource use secondary to hospital admissions.
© 2014 British HIV Association.

Entities:  

Keywords:  HIV; Shigella; homosexuality; male

Mesh:

Year:  2015        PMID: 25656740     DOI: 10.1111/hiv.12191

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  5 in total

1.  Brazilian Protocol for Sexually Transmitted Infections, 2020: sexually transmitted enteric infections.

Authors:  Edilbert Pelegrini Nahn Junior; Eduardo Campos de Oliveira; Marcelo Joaquim Barbosa; Thereza Cristina de Souza Mareco; Helena Andrade Brígido
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

2.  Use of gender distribution in routine surveillance data to detect potential transmission of gastrointestinal infections among men who have sex with men in England.

Authors:  P Mook; D Gardiner; S Kanagarajah; M Kerac; G Hughes; N Field; N McCarthy; C Rawlings; I Simms; C Lane; P D Crook
Journal:  Epidemiol Infect       Date:  2018-06-20       Impact factor: 4.434

3.  Notes from the Field: Outbreaks of Shigella sonnei Infection with Decreased Susceptibility to Azithromycin Among Men Who Have Sex with Men - Chicago and Metropolitan Minneapolis-St. Paul, 2014.

Authors:  Anna Bowen; Dana Eikmeier; Pamela Talley; Alicia Siston; Shamika Smith; Jacqueline Hurd; Kirk Smith; Fe Leano; Amelia Bicknese; J Corbin Norton; Davina Campbell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-05       Impact factor: 17.586

4.  Evaluation of whole-genome sequencing-based subtyping methods for the surveillance of Shigella spp. and the confounding effect of mobile genetic elements in long-term outbreaks.

Authors:  Isabelle Bernaquez; Christiane Gaudreau; Pierre A Pilon; Sadjia Bekal
Journal:  Microb Genom       Date:  2021-11

5.  Are enteric infections sexually transmitted in British Columbia?

Authors:  S Narayan; E Galanis
Journal:  Can Commun Dis Rep       Date:  2016-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.